How many employees work at Illimis Therapeutics?
Illimis Therapeutics, Inc. has approximately 51 total employees worldwide as of March 2026, according to Revelio Labs workforce intelligence data. Illimis Therapeutics’s total headcount has grown 2.8% from 50 employees in 2023 to 51 in 2026.
Is Illimis Therapeutics hiring right now?
No, Illimis Therapeutics is not actively hiring. Illimis Therapeutics had 0 active job postings in 2026, a 0.0% no change from 2025 — see job openings & hiring trends.
About Illimis Therapeutics’s Workforce
Illimis Therapeutics, Inc. is a Biotech and Healthcare Services company that employs 51 people worldwide as of March 2026. It is the 3rd-largest by headcount among its peers. Founded in 2021, the company is headquartered in Seoul, South Korea.
Illimis Therapeutics's workforce has grown 2.8% from 2023 to 2026, up 4.6% year over year in 2026. Its workforce is concentrated most in East Asia (89.4%), followed by North America (10.6%).
Illimis Therapeutics's functional groups are Finance and Operations (37.8%), Engineering (35.6%), and Sales and Marketing (26.6%), with Engineering growing fastest (up 12.1%). The average salary is $64,155, ranging from a median of $211,000 in North America to $41,000 in East Asia, up 16.8% year over year in 2026.
Illimis Therapeutics's hiring activity held steady in 2026.
Sourced from Revelio Labs workforce data.
- Headquarters
- Seoul, South Korea
- Founded
- 2021
- Industry
- Biotech and Healthcare Services
- Employees
- 51
- YoY
- +4.6% (+1)
As of March 2026
Illimis Therapeutics workforce metrics
Unlock hiring rate, attrition rate, and 12 additional workforce metrics for Illimis Therapeutics. Compare to peers, export the dataset, and access the full quarterly history.
Unlock MetricsIllimis Therapeutics Annual Employee Count (2023-2026)
- Illimis Therapeutics had 51 employees in 2026, a 4.6% increase (+1) from 2025.
- Illimis Therapeutics had 53 employees in 2025, a 4.3% increase (-1) from 2024.
- Illimis Therapeutics had 54 employees in 2024, a 4.3% increase (+1) from 2023.
- Illimis Therapeutics had 53 employees in 2023, a 5.3% increase (+10) from 2022.
Illimis Therapeutics's total workforce has grown from 50 employees in 2025 to 51 in 2026. Illimis Therapeutics's headcount peaked at 55 in 2024 before declining in 2025 and recovering through 2026.
Illimis Therapeutics, Inc. quarterly employee count
| Year | Qtr | Employees | YoY Change | YoY % |
|---|---|---|---|---|
| 2026 | Q1 | 51 | +1 | +4.6% |
| 2025 | Q4 | 53 | -1 | +4.3% |
| 2025 | Q3 | 53 | +2 | +8.2% |
| 2025 | Q2 | 54 | +3 | +11.0% |
| 2025 | Q1 | 50 | -5 | -1.8% |
| 2024 | Q4 | 54 | +1 | +4.3% |
| 2024 | Q3 | 51 | -3 | -1.3% |
| 2024 | Q2 | 51 | +1 | -1.4% |
| 2024 | Q1 | 55 | +9 | +13.5% |
| 2023 | Q4 | 53 | +10 | +5.3% |
| 2023 | Q3 | 54 | +26 | +15.7% |
| 2023 | Q2 | 50 | +26 | +19.3% |
See Illimis Therapeutics's complete headcount history, including quarterly breakdowns.
Get the DataIllimis Therapeutics Employee Count by Region (2026)
East Asia accounts for the largest share of Illimis Therapeutics's global workforce with approximately 89% of total employees, followed by North America.
Illimis Therapeutics employees by region
| Region | Employees | % of Total |
|---|---|---|
| East Asia | 46 | 89.4% |
| North America | 5 | 10.6% |
Drill into city-level data, hiring trends by region, and historic geographic shifts.
Unlock Geographic DataIllimis Therapeutics Employee Count by Department (2026)
Illimis Therapeutics's employee groups are Finance and Operations (37.8%), Engineering (35.6%), and Sales and Marketing (26.6%).
Illimis Therapeutics employees by department
| Department | Employees | % of Total |
|---|---|---|
| Finance and Operations | 19 | 37.8% |
| Engineering | 18 | 35.6% |
| Sales and Marketing | 14 | 26.6% |
Compare Illimis Therapeutics's department mix to industry peers.
See Full DataIllimis Therapeutics Employee Salary by Region (2026)
Illimis Therapeutics's average employee salary is $64,155 globally. Employees in North America receive the highest compensation, with median pay approximately 3.3x the global average. Pay is lowest in East Asia, at a median of $41,000.
Illimis Therapeutics median employee salary by region (USD)
| Region | Median Salary |
|---|---|
| North America | $211,000 |
| East Asia | $41,000 |
Unlock salary by role, level, and city — and compare to Illimis Therapeutics's industry peers.
Unlock Salary DataIllimis Therapeutics Job Openings and Hiring Trends (2023-2026)
- Illimis Therapeutics had 0 active job postings in 2026, a 0% no change (-1) from 2025.
- Illimis Therapeutics had 1 active job postings in 2025, a 200.0% increase (+1) from 2024.
- Illimis Therapeutics had 0 active job postings in 2024, a 0% no change from 2023.
- Illimis Therapeutics had 0 active job postings in 2023, a 0% no change from 2022.
- Hiring velocity in 2026: 0 new roles/month, up from 0 in 2025 and 0 in 2024.
Illimis Therapeutics's hiring activity held steady in 2026.
Track new postings per month, role-level demand, and hiring velocity vs. peers.
Unlock Hiring DataSimilar Companies
Similar Biotech and Healthcare Services Companies by Employee Count
Frequently Asked Questions About Illimis Therapeutics
- How fast is Illimis Therapeutics growing?
- In 2026, Illimis Therapeutics's headcount grew 4.6% to 51 employees, up from 50 in 2025.
- See the full headcount history
- Where are Illimis Therapeutics employees located?
- Most Illimis Therapeutics employees are based in East Asia (89.4% of headcount), followed by North America.
- Explore where the workforce is based
- What is the average salary at Illimis Therapeutics?
- The average employee salary at Illimis Therapeutics is approximately $64.2k per year.
- Analyze the salary distribution
- How many new job postings does Illimis Therapeutics open per year?
- In Q1 2026, Illimis Therapeutics opened 0 new job postings. In 2025, Illimis Therapeutics opened 1 new job postings — about 0 per month.
- Track hiring trends by role
- When was Illimis Therapeutics founded and where is it headquartered?
- Illimis Therapeutics was founded in 2021 and is headquartered in Seoul, South Korea.
- Compare Illimis Therapeutics to industry peers
Speak with a workforce expert about Illimis Therapeutics.
Book a DemoSee something that doesn't look right? Reach out and our team will review it.